BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29341562)

  • 21. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
    Márquez Moreno AJ; Mañas Uxó J; Amores Ramírez F; Aguilar Cuevas R; Ortega Jiménez MV; Leiva Vera C; Pérez Rodríguez D
    Arch Esp Urol; 2003 May; 56(4):415-7. PubMed ID: 12830613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of nasal Mantle cell lymphoma.
    Dahanayake G; Rokade A; Ghosh S; Raut V
    Kulak Burun Bogaz Ihtis Derg; 2010; 20(1):44-7. PubMed ID: 20163337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common malignancies with uncommon sites of presentation: case 2. Mantle-cell lymphoma of the prostate.
    Chim CS; Loong F; Yau T; Ooi GC; Liang R
    J Clin Oncol; 2003 Dec; 21(23):4456-8. PubMed ID: 14645437
    [No Abstract]   [Full Text] [Related]  

  • 25. An unusual pathological finding of chronic lymphocitic leukemia and adenocarcinoma of the prostate after transurethral resection for complete urinary retention: case report.
    Ballario R; Beltrami P; Cavalleri S; Ruggera L; Zorzi MG; Artibani W
    BMC Cancer; 2004 Dec; 4():95. PubMed ID: 15615590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma].
    Yoshida K; Kayano H; Shimada T; Wakao D; Takahashi N; Sugahara Y; Yagasaki F; Ito Y; Kawai N; Matsuda A; Suzuki T; Bessho M
    Rinsho Ketsueki; 2003 Mar; 44(3):174-81. PubMed ID: 12722344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
    Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
    J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
    Colonias A; Farinash L; Miller L; Jones S; Medich DS; Greenberg L; Miller R; Parda DS
    Nat Clin Pract Oncol; 2005 May; 2(5):271-4; quiz 1 p following 274. PubMed ID: 16264963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course.
    Liu Y; Li P; Guo Y; Fan L; Wang L; Zhu J; Huang G; Yan Q; Wang Z
    Am J Clin Pathol; 2014 May; 141(5):737-41. PubMed ID: 24713749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
    Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
    [No Abstract]   [Full Text] [Related]  

  • 31. Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.
    Lee MH; Lin YC; Cheng HT; Chuang WY; Huang HC; Kao HW
    World J Gastroenterol; 2015 Dec; 21(45):12981-6. PubMed ID: 26668520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative glomerulonephritis and mantle cell lymphoma: a rare association.
    Mhedhbi B; Chargui S; Harzallah A; Goucha R
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33547121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
    Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
    Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple cancer: chronic lymphocytic leukemia with bladder and prostate carcinoma.
    Gajendra S; Sharma R; Sahoo MK
    Malays J Pathol; 2015 Aug; 37(2):159-63. PubMed ID: 26277675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results.
    Ruan J; Gregory SA; Christos P; Martin P; Furman RR; Coleman M; Leonard JP
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):107-13. PubMed ID: 24373788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
    Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
    Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous male breast cancer and carcinoma of prostate in 90-year-old male, presented with spinal cord compression and multiple spine lytic lesions.
    Grenader T; Shavit L
    Breast J; 2007; 13(4):410-2. PubMed ID: 17593047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
    Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
    Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation for mantle cell lymphoma: is it the right thing to do?
    Williams ME
    Hematology Am Soc Hematol Educ Program; 2013; 2013():568-74. PubMed ID: 24319233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.